Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 4

Evaluation of the relationship between dyssynchrony and myocardial fibrosis markers in patients with cardiac resynchronization therapy

Pages
1234–1240
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is determined a negative relationship between EF and PICP level and PICP / ICTP ratio (p=0.008, r = -0.37).Conclusion: Our results show that CRT reduces the left ventricular dyssynchrony and consequently leads to favor-able changes in myocardial fibrosis markers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractAim: Dyssynchrony can be seen in some patients with heart failure.
📊
Key Findings & Data:The aim of this study is to evaluate myocardial fibrosis markers in patients with heart failure CRT applied and to assess the relationship between these markers and dyssynchrony.Material and Methods: Fifty one patients (ejection fraction (EF) ≤ % 35, QRS duration ≥130 msec) were included into the study.
💡
Conclusion & Impact:It is determined a negative relationship between EF and PICP level and PICP / ICTP ratio (p=0.008, r = -0.37).Conclusion: Our results show that CRT reduces the left ventricular dyssynchrony and consequently leads to favor-able changes in myocardial fibrosis markers.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AbstractAim: Dyssynchrony can be seen in some patients with heart failure. The goal of cardiac resynchronization therapy (CRT) is the correction of dyssynchrony. The correction of myocardial loading and remodel-ing prevents development of the myocardial fibrosis. The aim of this study is to evaluate myocardial fibrosis markers in patients with heart failure CRT applied and to assess the relationship between these markers and dyssynchrony.Material and Methods: Fifty one patients (ejection fraction (EF) ≤ % 35, QRS duration ≥130 msec) were included into the study. Electrocardiography (ECG), 6 minute walking test, and echocardiography were applied before and 6 months after CRT to all patients. Furthermore, Type I Collagen C-Terminal Propeptide (PICP), Type I Collagen C-Terminal Telopeptide (ICTP) levels and PICP/ICTP ratio were studied as myocardi-al fibrosis markers in blood samples.Results: It is observed that QRS was shortened after CRT (p=0.0001). Six minute walking distance was in-creased 6 months after CRT (p=0.0001). PICP level measured before CRT as 560.2 ± 300.4 µg/L while it is measured as 476,9±285,8 µg/L 6 months after CRT (p=0.004). PICP/ICTP ratio before and 6 months after CRT was 9.7 ± 10 and 37.1 ± 32.8 respectively (p=0.0001). It is determined a negative relationship between EF and PICP level and PICP / ICTP ratio (p=0.008, r = -0.37).Conclusion: Our results show that CRT reduces the left ventricular dyssynchrony and consequently leads to favor-able changes in myocardial fibrosis markers. Reducing the mechanical stresses on left ventricle and returning of consequent remodeling may be one of the important mechanisms in the prevention of cardiac fibrosis.

🔖

Cite This Article

CEVHER, V., KARAASLAN, M. B., AKİLLİ, R., DENİZ, A., KANADASİ, M., USAL, A., Demir, M. (2022). Evaluation of the relationship between dyssynchrony and myocardial fibrosis markers in patients with cardiac resynchronization therapy. Annals of Medical Research, Cilt: 27 - Sayı: 4, 1234–1240. https://ajindex.com/articles/446468

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Mullens W, Tang WH, Grimm RA. Using echocardiography in cardiac resynchronization therapy. Am Heart J 2007;154:1011-20
  2. Hawkins NM, Pesrie MC, MacDonald MR, et al. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur Heart J 2006;27:1270-81
  3. Bax JJ, Marwick TH, Molhoek SG. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with endstage heart failure before pacemaker implantation. Am J Cardiol 2003;92:1238-40
  4. Ghio S, Freemantle N, Scelsi L, et al. Long-term left ventricular reverse remodeling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 2009;11:480-8
  5. Sunman H, Canpolat U, Yorgun H, et al. Association between reverse electrical remodeling and cardiac fibrosis markers in patients with cardiac resynchronization therapy. Turk Kardiyol Dern Ars 2018;46:84-91
  6. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2013;34:2281-329
  7. Otto CM. Left and right ventricular systolic function. In: Otto CM, ed. Textbook of clinical echo-cardiography. 3rd ed. Philadelphia: WB Saunders 2004:131-65
  8. Pitzalis MV, Iacoviello M, Romito R. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-22
  9. Cazeau S, Bordachar P, Jauvert G. Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol 2003;26:137-43
  10. Bax JJ, Ansalone G, Breithardt OA. Echocardiographic evaluation of cardiac resynchroniza-tion therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 2004;44:1-9
  11. Bax JJ, Molhoek SG, van Erven L. Usefulness of myocardial tissue Doppler echocardiog-raphy to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2003;91:94-7
  12. Bax JJ, Bleeker GB, Marwick TH. Left ventricular dyssynchrony predicts response and prog-nosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004; 44:1834-40
  13. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for ma